April Lynn Nizinski, LCSW | |
721 American Ave Ste 508, Waukesha, WI 53188-5071 | |
(262) 928-7898 | |
Not Available |
Full Name | April Lynn Nizinski |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 721 American Ave Ste 508, Waukesha, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174279269 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 9275-123 (Wisconsin) | Primary |
Entity Name | Prohealth Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356322440 PECOS PAC ID: 3476465188 Enrollment ID: O20031103000066 |
News Archive
Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
MAP Pharmaceuticals, Inc. announced today that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society.
Halozyme Therapeutics, Inc. today announced the issuance of U.S. Patent No. 7,767,429 claiming its proprietary recombinant human hyaluronidase enzyme platform (rHuPH20). Claims to the human PH20 glycoprotein, PEGylated variants, the glycoprotein produced by recombinant methods, and pharmaceutical compositions with other agents, including antibodies, insulins, cytokines, anti-infectives and additional therapeutic classes were awarded in the '429 patent. Additional claims are in prosecution.
St. Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
April Lynn Nizinski, LCSW 812 National Ave, Waukesha, WI 53186-5145 Ph: (414) 916-6225 | April Lynn Nizinski, LCSW 721 American Ave Ste 508, Waukesha, WI 53188-5071 Ph: (262) 928-7898 |
News Archive
Singulex, Inc., the developer and leading provider of Single Molecule Counting (SMC) technology for clinical diagnostics and scientific discovery, today announced an agreement to co-develop the Sgx Clarity system with Tecan, a leading global provider of laboratory automation instruments.
Ultrasound is transforming the way arthritis is diagnosed and treated, making evaluation and treatment quicker and more accurate. The new approach is dubbed fast arthritis sonographic evaluation and treatment, or FAST, by rheumatologists at NewYork-Presbyterian Hospital/Columbia University Medical Center who are leading its development.
MAP Pharmaceuticals, Inc. announced today that it will present analysis of data from the efficacy portion of the first Phase 3 trial of its novel LEVADEX orally inhaled migraine therapy, currently in development, at the 14th Congress of the International Headache Society.
Halozyme Therapeutics, Inc. today announced the issuance of U.S. Patent No. 7,767,429 claiming its proprietary recombinant human hyaluronidase enzyme platform (rHuPH20). Claims to the human PH20 glycoprotein, PEGylated variants, the glycoprotein produced by recombinant methods, and pharmaceutical compositions with other agents, including antibodies, insulins, cytokines, anti-infectives and additional therapeutic classes were awarded in the '429 patent. Additional claims are in prosecution.
St. Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function.
› Verified 4 days ago
Ms. Natasha Jean Pinkerton, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 725 American Ave, Waukesha, WI 53188 Phone: 262-928-1000 | |
Mr. Jerome Michael Loberg, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1501 Airport Rd., Waukesha, WI 53188 Phone: 262-548-7930 | |
Cindy M Sywyk, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 721 American Ave, Suite 501, Waukesha, WI 53188 Phone: 262-928-2396 Fax: 262-544-1213 | |
Gary Swan, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2607 N Grandview Blvd, Suite 104, Waukesha, WI 53188 Phone: 262-446-9981 Fax: 262-446-9983 | |
Robert K Porter, MSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 721 American Ave, Suite 501, Waukesha, WI 53188 Phone: 262-928-2396 Fax: 262-544-1213 | |
Susan L Driscoll, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1501 Airport Rd, Waukesha, WI 53188 Phone: 262-548-7950 | |
Marilyn Tauscher, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 721 American Ave, Ste 501, Waukesha, WI 53188 Phone: 262-928-4036 |